CMR Surgical, a global leader in surgical robotics, has successfully closed a financing round exceeding US$200m.
The funding, a combination of equity and debt capital, aims to support the company’s ambitious growth plans. Existing major investors in CMR participated in the round, with Trinity Capital providing a new debt investment, demonstrating strong confidence in the company’s vision and future prospects.
The capital raised will be used to accelerate the commercial expansion of CMR’s Versius Surgical Robotic System, with a particular focus on expanding its presence in hospitals worldwide, especially in the United States.
The funds will also support the continued advancement of surgical robotics innovation, including the launch of the enhanced Versius Plus.
Versius, reportedly the second most utilised soft tissue surgical robot globally, has already been used in more than 30,000 surgeries across more than 30 countries.
It has been employed in a wide range of procedures, including colorectal, general, gynaecology, thoracic, and urology surgeries. The increase in Versius installations reflects the growing adoption of surgical robotics and highlights the system’s versatility and strong market differentiation.
In addition to its commercial efforts, CMR is expanding its clinical presence through two ongoing clinical trials. One is a groundbreaking paediatric study, the first multi-centre prospective trial focused on using Versius in paediatric surgery.
The other is a transoral robotic surgery (TORS) trial, further showcasing the system’s potential in new surgical applications.
Massimiliano Colella, chief executive officer at CMR Surgical, said: “CMR is a competitive, well-established company with a transformative product providing clear clinical value. We are now at a pivotal stage, poised to capitalise on significant opportunities for market expansion, including in the US, while continuing to penetrate deeper into existing markets.
“I would like to give thanks to our CFO, Andre Nel, and the team for securing this financing to provide the foundation for realising our strategic vision of making robotic assisted surgery accessible to all patients who need it whilst accelerating future product development.”
Achievements and innovations in retail and e-commerce, healthcare and pharmaceuticals, food and beverage, automotive, transport & logistics, and more will be celebrated at the Robotics & Automation Awards on 29 October 2025 at De Vere Grand Connaught Rooms in London. Visit www.roboticsandautomationawards.co.uk to learn more about this unmissable event for the UK’s robotics and automation sectors!
